Tag: Weight Loss Medication
Tirzepatide Cuts Type 2 Diabetes Risk by 94% in Obese Adults...
In a groundbreaking 176-week SURMOUNT-1 Phase 3 study, Eli Lilly's tirzepatide significantly reduced the risk of developing type 2 diabetes by 94% in adults...